VanEck Vectors制药ETF PPH 深 沪
等待开盘 09-19 09:30:00 美东时间
88.87
+0.290
+0.33%
华盛通- 最 高89.10
- 今 开88.69
- 成交量 13.97万股
- 最 低 88.69
- 昨 收 88.58
- 总市值 5.68亿
- 52周最高 93.9989
- 市盈率 静 --
- 换手率 2.19%
- 52周最低 77.0631
- 委 比 17.43%
- 总股本 638.81万
- 历史最高 97.5586
- 量 比 0.38
- 振 幅 0.46%
- 历史最低 32.0136
- 每 手 1
- 风险率 3.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
ProPhase Labs shareholders overwhelmingly approved all proposals at the September 9 special meeting, with over 75% support for each item. This included authorization to increase the company's authorized shares to 1 billion, enabling strategic initiatives like a potential crypto treasury strategy and growth of its subsidiaries. The meeting follows the re-election of the board in June with over 90% support. CEO Ted Karkus emphasized the mandate all...
09-12 12:00
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
09-08 13:49
Pullback presents buying opportunities as market will resume higher – PNC’s Yung-Yu Ma
PNC asset management chief investment strategist Yung-Yu Ma believes market pullbacks present buying opportunities despite growing concerns about weakening labor trends, as the market initially reacte...
09-06 00:02
PPHE Hotel Group Director Increases Shareholding
PPHE Hotel ( ($GB:PPH) ) has issued an update. PPHE Hotel Group announced that ...
09-03 22:22
Citi’s Drew Pettit: Stocks are seeing a ‘healthy reset,’ not cause for concern
Citigroup’s director of U.S. equity strategy Drew Pettit described recent market declines as a “healthy reset” rather than a reason for alarm. In an interview with CNBC, Pettit emphasized that despite...
09-03 03:38
Morgan Stanley’s Mike Wilson: Healthcare could rebound amid near record low valuations
Healthcare’s (NYSEARCA:XLV) market cap weight in the S&P 500 (SP500) and its relative forward P/E ratio are hovering around historical lows, but several factors could trigger a sentiment improvement, ...
09-02 23:15
Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales
Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.
07-31 22:10
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
ProPhase Labs, Inc. has closed a $3 million private placement financing with senior secured convertible notes and warrants to support working capital, debt repayment, and crypto strategies. The notes, with a 20% original issue discount, are not convertible for the first four months. Proceeds will also aid in pursuing liquidity events like collecting Covid accounts receivable and selling Nebula Genomics. The company aims to explore a reverse merge...
07-23 12:00
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative
The Board of Directors of ProPhase Labs, Inc. authorized the exploration of a potential reverse merger with a digital asset-focused company to enhance shareholder value and diversify its treasury strategy by acquiring and holding selected digital assets, including Bitcoin. This initiative reflects the company's interest in leveraging opportunities at the intersection of life sciences and financial innovation. ProPhase Labs aims to create scalable...
07-21 12:00
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equities, they named REVS. UBS’s REVS framework consists of elements that are key drivers for equity performance, inc...
07-11 23:33
公司简介
公司名称
|
VanEck Vectors制药ETF
|
行业分类
|
--
|
业务描述
|
Exists as exchange Traded Fund
|
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
ProPhase Labs shareholders overwhelmingly approved all proposals at the September 9 special meeting, with over 75% support for each item. This included authorization to increase the company's authorized shares to 1 billion, enabling strategic initiatives like a potential crypto treasury strategy and growth of its subsidiaries. The meeting follows the re-election of the board in June with over 90% support. CEO Ted Karkus emphasized the mandate all...
09-12 12:00
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
09-08 13:49
Pullback presents buying opportunities as market will resume higher – PNC’s Yung-Yu Ma
PNC asset management chief investment strategist Yung-Yu Ma believes market pullbacks present buying opportunities despite growing concerns about weakening labor trends, as the market initially reacte...
09-06 00:02
PPHE Hotel Group Director Increases Shareholding
PPHE Hotel ( ($GB:PPH) ) has issued an update. PPHE Hotel Group announced that ...
09-03 22:22
Citi’s Drew Pettit: Stocks are seeing a ‘healthy reset,’ not cause for concern
Citigroup’s director of U.S. equity strategy Drew Pettit described recent market declines as a “healthy reset” rather than a reason for alarm. In an interview with CNBC, Pettit emphasized that despite...
09-03 03:38
Morgan Stanley’s Mike Wilson: Healthcare could rebound amid near record low valuations
Healthcare’s (NYSEARCA:XLV) market cap weight in the S&P 500 (SP500) and its relative forward P/E ratio are hovering around historical lows, but several factors could trigger a sentiment improvement, ...
09-02 23:15
Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales
Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.
07-31 22:10
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
ProPhase Labs, Inc. has closed a $3 million private placement financing with senior secured convertible notes and warrants to support working capital, debt repayment, and crypto strategies. The notes, with a 20% original issue discount, are not convertible for the first four months. Proceeds will also aid in pursuing liquidity events like collecting Covid accounts receivable and selling Nebula Genomics. The company aims to explore a reverse merge...
07-23 12:00
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative
The Board of Directors of ProPhase Labs, Inc. authorized the exploration of a potential reverse merger with a digital asset-focused company to enhance shareholder value and diversify its treasury strategy by acquiring and holding selected digital assets, including Bitcoin. This initiative reflects the company's interest in leveraging opportunities at the intersection of life sciences and financial innovation. ProPhase Labs aims to create scalable...
07-21 12:00
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equities, they named REVS. UBS’s REVS framework consists of elements that are key drivers for equity performance, inc...
07-11 23:33
年度
|
派息内容
| 派息日期 |
0.61
|
2025-07-07
| |
0.52
|
2025-04-04
| |
0.41
|
2024-12-30
| |
0.41
|
2024-10-04
| |
0.36
|
2024-07-05
| |
0.53
|
2024-04-05
| |
0.31
|
2023-12-29
| |
0.34
|
2023-10-06
| |
0.39
|
2023-07-07
| |
0.66
|
2023-04-10
| |
0.24
|
2022-12-30
| |
0.27
|
2022-10-07
| |
0.25
|
2022-07-08
| |
0.44
|
2022-04-07
| |
0.27
|
2021-12-31
| |
0.35
|
2021-10-07
| |
0.29
|
2021-07-08
| |
0.35
|
2021-04-08
| |
0.27
|
2021-01-05
| |
0.25
|
2020-10-07
| |
0.25
|
2020-07-07
| |
0.34
|
2020-04-07
| |
0.17
|
2020-01-06
| |
0.29
|
2019-10-07
| |
0.28
|
2019-07-08
| |
0.39
|
2019-04-05
| |
0.20
|
2019-01-03
| |
0.23
|
2018-10-05
| |
0.25
|
2018-07-09
| |
0.39
|
2018-04-06
| |
0.15
|
2018-01-03
| |
0.22
|
2017-10-06
| |
0.30
|
2017-07-10
| |
0.47
|
2017-04-07
| |
0.14
|
2017-01-04
| |
0.21
|
2016-10-07
| |
0.29
|
2016-07-08
| |
0.63
|
2016-04-07
| |
0.20
|
2016-01-05
| |
0.28
|
2015-10-07
| |
0.28
|
2015-07-08
| |
0.50
|
2015-04-08
| |
0.24
|
2015-01-05
| |
0.20
|
2014-10-07
| |
0.25
|
2014-07-08
| |
0.40
|
2014-04-07
| |
0.17
|
2014-01-03
| |
0.21
|
2013-10-07
| |
0.27
|
2013-07-08
| |
0.39
|
2013-04-05
| |
1.35
|
2012-12-31
| |
0.04
|
2012-02-03
| |
0.13
|
2012-01-11
| |
0.15
|
2011-12-15
| |
0.05
|
2011-12-13
| |
0.14
|
2011-12-08
| |
0.07
|
2011-11-17
| |
0.06
|
2011-11-03
| |
0.11
|
2011-10-12
| |
0.15
|
2011-09-15
| |
0.001
|
2011-09-12
| |
0.05
|
2011-09-13
| |
0.14
|
2011-09-08
| |
0.07
|
2011-08-17
| |
0.05
|
2011-08-03
| |
0.11
|
2011-07-12
| |
0.15
|
2011-06-16
| |
0.001
|
2011-06-14
| |
0.19
|
2011-06-09
| |
0.07
|
2011-05-18
| |
0.05
|
2011-05-04
| |
0.11
|
2011-04-11
| |
0.61
|
2011-03-10
| |
0.14
|
2011-03-17
| |
0.001
|
2011-03-15
| |
0.05
|
2011-03-14
| |
0.14
|
2011-03-03
| |
0.06
|
2011-02-17
| |
0.06
|
2011-02-03
| |
0.11
|
2011-01-11
| |
0.14
|
2010-12-16
| |
0.04
|
2010-12-24
| |
0.001
|
2010-12-03
| |
0.12
|
2010-12-03
| |
0.06
|
2010-11-17
| |
0.06
|
2010-11-03
| |
0.11
|
2010-10-12
| |
0.004
|
2010-10-06
| |
0.14
|
2010-09-16
| |
0.001
|
2010-09-09
| |
0.05
|
2010-09-14
| |
0.13
|
2010-09-03
| |
0.06
|
2010-08-18
| |
0.06
|
2010-08-04
| |
0.11
|
2010-07-12
| |
0.003
|
2010-07-07
| |
0.14
|
2010-06-17
| |
0.001
|
2010-06-10
| |
0.04
|
2010-06-14
| |
0.13
|
2010-06-03
| |
0.06
|
2010-05-19
| |
0.06
|
2010-05-05
| |
0.11
|
2010-04-09
| |
0.003
|
2010-04-07
| |
0.13
|
2010-03-11
| |
0.001
|
2010-03-16
| |
0.05
|
2010-03-12
| |
0.13
|
2010-03-04
| |
0.06
|
2010-02-18
| |
0.06
|
2010-02-03
| |
0.11
|
2010-01-12
| |
0.004
|
2010-01-06
| |
0.13
|
2009-12-10
| |
0.05
|
2009-12-14
| |
1.47
|
2009-11-16
| |
0.001
|
2009-12-02
| |
0.11
|
2009-12-03
| |
0.009
|
2009-12-02
| |
3.96
|
2009-10-27
| |
0.06
|
2009-11-04
| |
0.08
|
2009-10-05
| |
0.003
|
2009-10-07
| |
0.13
|
2009-09-10
| |
0.001
|
2009-09-10
| |
0.05
|
2009-09-14
| |
0.04
|
2009-09-03
| |
0.10
|
2009-09-04
| |
0.06
|
2009-08-19
| |
0.06
|
2009-08-05
| |
0.17
|
2009-07-03
| |
0.13
|
2009-06-11
| |
0.001
|
2009-06-10
| |
0.05
|
2009-07-08
| |
0.04
|
2009-06-03
| |
0.09
|
2009-06-04
| |
0.009
|
2009-05-28
| |
0.06
|
2009-05-19
| |
0.05
|
2009-05-05
| |
0.01
|
2009-04-08
| |
0.13
|
2009-04-03
| |
0.12
|
2009-03-12
| |
0.001
|
2009-03-17
| |
0.09
|
2009-03-04
| |
0.19
|
2009-03-05
| |
0.05
|
2009-02-19
| |
0.06
|
2009-02-04
| |
0.01
|
2009-01-07
| |
0.08
|
2009-01-06
| |
0.12
|
2008-12-11
| |
0.05
|
2008-12-12
| |
0.04
|
2008-12-03
| |
0.001
|
2008-12-03
| |
0.19
|
2008-12-04
| |
0.05
|
2008-11-19
| |
0.06
|
2008-10-05
| |
0.08
|
2008-10-03
| |
0.12
|
2008-09-11
| |
0.01
|
2008-09-05
| |
0.05
|
2008-09-09
| |
0.03
|
2008-09-04
| |
0.19
|
2008-09-05
| |
0.009
|
2008-08-28
| |
0.05
|
2008-08-19
| |
0.06
|
2008-08-05
| |
0.08
|
2008-07-03
| |
0.12
|
2008-06-12
| |
0.001
|
2008-06-17
| |
0.01
|
2008-06-03
| |
0.05
|
2008-06-12
| |
0.03
|
2008-06-04
| |
0.19
|
2008-06-05
| |
0.009
|
2008-05-29
| |
0.05
|
2008-05-19
| |
0.06
|
2008-05-05
| |
0.01
|
2008-04-07
| |
0.08
|
2008-04-03
| |
0.11
|
2008-03-13
| |
0.05
|
2008-03-12
| |
0.03
|
2008-03-05
| |
0.19
|
2008-03-06
| |
0.009
|
2008-02-28
| |
0.05
|
2008-02-20
| |
0.05
|
2008-02-05
| |
0.08
|
2008-01-04
| |
0.11
|
2007-12-13
| |
0.01
|
2007-12-04
| |
0.04
|
2007-12-12
| |
0.010
|
2007-12-04
| |
0.03
|
2007-12-05
| |
0.17
|
2007-12-06
| |
0.009
|
2007-11-29
| |
0.05
|
2007-11-19
| |
0.05
|
2007-11-05
| |
0.08
|
2007-10-03
| |
0.11
|
2007-09-13
| |
0.01
|
2007-09-05
| |
0.001
|
2007-09-11
| |
0.04
|
2007-09-12
| |
0.03
|
2007-09-06
| |
0.17
|
2007-09-07
| |
0.009
|
2007-08-30
| |
0.05
|
2007-08-17
| |
0.05
|
2007-08-03
| |
0.001
|
2007-07-18
| |
0.01
|
2007-09-05
| |
0.08
|
2007-07-05
| |
0.11
|
2007-06-14
| |
0.01
|
2007-05-31
| |
0.001
|
2007-06-12
| |
0.08
|
2007-06-12
| |
0.20
|
2007-06-05
| |
0.009
|
2007-05-31
| |
0.05
|
2007-05-17
| |
0.05
|
2007-05-03
| |
0.001
|
2007-04-18
| |
0.01
|
2007-04-05
| |
0.08
|
2007-04-04
| |
0.10
|
2007-03-15
| |
0.001
|
2007-03-13
| |
0.04
|
2007-03-13
| |
0.03
|
2007-03-05
| |
0.17
|
2007-03-08
| |
0.008
|
2007-03-01
| |
0.04
|
2007-02-20
| |
0.02
|
2007-01-24
| |
0.001
|
2007-01-08
| |
0.08
|
2007-01-04
| |
0.005
|
2006-12-04
| |
0.04
|
2006-12-12
| |
0.03
|
2006-12-05
| |
0.64
|
2006-12-07
| |
0.008
|
2006-11-30
| |
0.04
|
2006-11-17
| |
0.05
|
2006-11-03
| |
0.001
|
2006-10-18
| |
0.08
|
2006-10-04
| |
0.10
|
2006-09-14
| |
0.006
|
2006-09-14
| |
0.0008
|
2006-09-05
| |
0.04
|
2006-09-12
| |
0.16
|
2006-09-07
| |
0.008
|
2006-08-31
| |
0.04
|
2006-08-17
| |
0.05
|
2006-08-03
| |
0.001
|
2006-07-18
| |
0.08
|
2006-07-06
| |
0.10
|
2006-06-15
| |
0.004
|
2006-06-02
| |
0.001
|
2006-06-15
| |
0.0008
|
2006-06-05
| |
0.04
|
2006-06-13
| |
0.16
|
2006-06-08
| |
0.008
|
2006-06-01
| |
0.04
|
2006-05-17
| |
0.06
|
2006-05-02
| |
0.003
|
2006-04-19
| |
0.0008
|
2006-04-03
| |
0.08
|
2006-04-05
| |
0.09
|
2006-03-16
| |
0.001
|
2006-03-16
| |
0.04
|
2006-03-14
| |
0.03
|
2006-03-03
| |
0.13
|
2006-03-09
| |
0.62
|
2006-03-02
| |
0.04
|
2006-02-17
| |
0.05
|
2006-02-03
| |
0.001
|
2006-01-18
| |
0.08
|
2006-01-06
| |
0.02
|
2005-12-16
| |
0.09
|
2005-12-15
| |
0.0008
|
2005-12-05
| |
0.001
|
2005-12-14
| |
0.03
|
2005-12-13
| |
0.14
|
2005-12-05
| |
0.008
|
2005-12-01
| |
0.04
|
2005-11-17
| |
0.05
|
2005-11-03
| |
0.001
|
2005-10-19
| |
0.08
|
2005-10-05
| |
0.09
|
2005-09-15
| |
0.0008
|
2005-09-06
| |
0.05
|
2005-08-03
| |
0.001
|
2005-07-19
| |
0.08
|
2005-06-07
| |
0.18
|
2005-06-10
| |
0.008
|
2005-06-02
| |
0.05
|
2005-05-04
| |
0.0007
|
2005-04-19
| |
0.08
|
2005-04-05
| |
0.11
|
2005-03-14
| |
0.001
|
2005-03-14
| |
0.11
|
2005-03-03
| |
0.008
|
2005-03-02
| |
0.04
|
2005-02-17
| |
0.0008
|
2005-01-28
| |
0.05
|
2005-02-03
| |
0.0007
|
2005-01-19
| |
0.08
|
2005-01-05
| |
0.07
|
2004-12-09
| |
0.03
|
2004-12-14
| |
0.09
|
2004-12-07
| |
0.0009
|
2004-12-13
| |
0.008
|
2004-12-02
| |
0.04
|
2004-11-17
| |
0.0008
|
2004-10-29
| |
0.05
|
2004-11-04
| |
0.0007
|
2004-10-19
| |
0.08
|
2004-10-05
| |
0.0009
|
2004-09-20
| |
0.07
|
2004-09-09
| |
0.12
|
2004-09-08
| |
0.008
|
2004-09-02
| |
0.04
|
2004-08-18
| |
0.0008
|
2004-07-30
| |
0.05
|
2004-08-04
| |
0.0007
|
2004-07-19
| |
0.08
|
2004-07-06
| |
0.07
|
2004-06-10
| |
0.12
|
2004-06-14
| |
0.03
|
2004-06-03
| |
0.0009
|
2004-06-14
| |
0.008
|
2004-06-02
| |
0.04
|
2004-05-19
| |
0.0008
|
2004-04-30
| |
0.05
|
2004-05-05
| |
0.0007
|
2004-04-19
| |
0.08
|
2004-04-05
| |
0.06
|
2001-09-10
| |
0.02
|
2001-09-12
| |
0.03
|
2001-09-04
| |
0.02
|
2001-08-30
| |
0.03
|
2001-08-17
| |
0.0008
|
2001-07-27
| |
0.04
|
2001-08-03
| |
0.0004
|
2001-07-18
| |
0.07
|
2001-07-03
| |
0.05
|
2001-06-13
| |
0.06
|
2001-06-18
| |
0.02
|
2001-06-12
| |
0.03
|
2001-06-04
| |
0.02
|
2001-05-30
| |
0.03
|
2001-05-16
| |
0.0008
|
2001-04-26
| |
0.04
|
2001-05-02
| |
0.0004
|
2001-04-17
| |
0.07
|
2001-04-03
| |
0.04
|
2001-03-14
| |
0.0009
|
2001-03-19
| |
0.02
|
2001-03-12
| |
0.03
|
2001-03-02
| |
0.02
|
2001-02-28
| |
0.04
|
2001-02-02
| |
0.0004
|
2001-01-16
| |
0.07
|
2001-01-03
| |
0.04
|
2000-12-13
| |
0.0008
|
2000-12-11
| |
0.03
|
2000-12-04
| |
0.02
|
2000-11-29
| |
0.0007
|
2000-10-31
| |
0.03
|
2000-11-16
| |
0.04
|
2000-11-02
| |
0.0004
|
2000-10-16
| |
0.07
|
2000-10-03
| |
0.0008
|
2000-09-18
| |
0.04
|
2000-09-13
| |
0.05
|
2000-09-08
| |
0.03
|
2000-09-12
| |
0.03
|
2000-09-05
| |
0.02
|
2000-08-30
| |
0.0007
|
2000-08-04
| |
0.03
|
2000-08-16
| |
0.04
|
2000-08-02
| |
0.0004
|
2000-07-17
| |
0.0003
|
2000-07-05
| |
0.06
|
2000-07-05
| |
0.0008
|
2000-06-19
| |
0.04
|
2000-06-14
| |
0.03
|
2000-06-12
| |
0.03
|
2000-06-02
| |
0.03
|
2000-06-09
| |
0.02
|
2000-05-31
| |
0.02
|
2000-05-15
| |
0.03
|
2000-05-16
| |
0.010
|
2000-05-02
| |
0.04
|
2000-05-02
| |
0.0002
|
2000-04-04
| |
0.06
|
2000-04-04
| |
0.03
|
2000-03-13
| |
0.05
|
2000-03-13
|
